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The quality of a consultation provided by a physician can have a profound impact on the quality of care and
patient engagement in treatment decisions. When the COPD Assessment Test (CAT) was developed, one of its aims
was to aid the communication between physician and patient about the impact of COPD. We developed a novel
study design to assess this in a primary care consultation.
Primary care physicians across five countries in Europe conducted videoed consultations with six standardised
COPD patients (played by trained actors) which had patient-specific issues that the physician needed to identify
through questioning. Half the physicians saw the patients with the completed CAT, and half without. Independent
assessors scored the physicians on their ability to identify and address the patient-specific issues, review standard
COPD aspects, their understanding of the case and their overall performance. This novel study design presented
many challenges which needed to be addressed to achieve an acceptable level of robustness to assess the utility of
the CAT. This paper discusses these challenges and the measures adopted to eliminate or minimise their impact on
the study results.
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The quality of a consultation provided by a physician
can have a profound impact on the quality of care and
patient engagement in treatment decisions [1]. The most
effective consultations are those in which doctors most
directly acknowledge and respond to patients’ problems
and concerns [2]. Limited time for consultations forces
primary care physicians to focus on the fundamental
problems, and patients often do not present all of their
problems and concerns in a consultation, which can lead
to poor consultation outcome [3]. Thus, tools to im-
prove the communication between patient and physician
have the potential to improve consultation outcomes.
The COPD Assessment Test (CAT) is a new, patient
completed questionnaire designed to provide a simple
and reliable measure of health status in a patient with
COPD [4]. The CAT questionnaire is formed of 8 ques-
tions covering the most burdensome symptoms of
COPD. The CAT has undergone robust validation* Correspondence: Helen.c.marsden@gsk.com
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distribution, and reproduction in any mediumtesting, and has been shown to have very similar proper-
ties to the more complex health status questionnaires,
the St George’s Respiratory Questionnaire (SGRQ) [5]
and the Chronic Respiratory Questionnaire [6]. However,
it is shorter, making it suitable for routine clinical use.
In general, once a patient reported outcome measure
(PROM) has been developed and validated, there needs
to be an assessment of whether it improves patient care
[7]. When the CAT was developed, one of its aims was
to aid the communication between physician and patient
on the impact of COPD, and thus aid physicians to opti-
mise the patients’ care [4]. However, to date, this aspect
of the CAT has not been tested. We therefore set out to
conduct a study to assess the impact of a PROM, the
CAT, on physician-patient communication.
Such a research question presents several challenges
to researchers: How to ensure a fair comparison between
arms; how to assess the impact of the PROM; and how
to conduct a study large enough (both sample size and
geographical spread) to give robust and generalisable re-
sults? This paper discusses the feasibility of a novel study
which was designed to address many of these challenges.Central Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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This was a single visit, randomised (1:1) open, parallel
group study (Figure 1). The UK’s National Research
Ethics Services confirmed ethical approval was not re-
quired, and physicians consented to their participation
in the study.
Physician recruitment
The CAT had been launched by the time the study com-
menced and was already being used by some secondary
care respiratory specialists. The study therefore focused
on the primary care setting to aid recruitment and to
assess the CAT where the impact of its use is unknown.
Physicians across five European countries (United
Kingdom (UK), Ireland, France, Germany and Austria)
were contacted by a local market research agency and
screened by telephone interview. Those reporting experi-
ence of managing COPD patients (at least three), but
not of using the CAT, were invited to participate in a
physician-patient communication study. A total of 168
physicians agreed to participate in the study, of which
three failed to attend their allotted filming session. The
selection of the physicians was not random due to the
practicalities of the study, which required twelveConsultatio
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Figure 1 Study design. (A) Physicians were randomised to conduct consu
CAT; (B) The physician: patient consultations were videoed for assessment.
COPD Assessment Test.physicians who were willing to participate in the study
and within travelling distance of suitable filming facil-
ities. Potential biases of location (rural versus urban-
based physician) and specific interest or expertise in re-
spiratory diseases were considered. Location (rural ver-
sus urban within an individual country) is unlikely to
affect physician communication skills, but knowledge of
COPD and the CAT may have done. The screening
questions therefore also covered experience of managing
asthma, use of Hospital Anxiety and Depression Score,
and Framingham risk such that physicians were unaware
that the study was about COPD and the CAT until they
attended their allocated sessions. Physicians were asked
again about whether they had a working knowledge of
the CAT when the attended the filming session to iden-
tify any physician who had used the CAT following the
screening interview. A total of nine physicians reported
experience of using the CAT on the day of filming.
These physicians were excluded from the primary ana-
lysis, along with any physicians who reported insufficient
experience of managing COPD patients on the day of
filming.
Two or four geographically-spread locations were used
in each country, depending on the number of physiciansn
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groups of five or six, with two groups recruited in each
location. Each group was randomised to see the patient
with (“CAT+” arm) or without (“no CAT” arm) the com-
pleted CAT during the consultation. A 2-level hierarch-
ical design was used, with a randomisation block size of
two, without stratification, such that one group was
randomised to each arm at each location. The recruiters
were blinded to the randomisation.
Physicians received brief training on COPD and those in
the CAT+ arm also received brief training on the CAT.
The training was provided in the form of reading material,
which for the CAT+ groups included background infor-
mation on the tool, how to interpret overall scores and
how to identify specific areas of concern for the patient.
Participants were given around 20 minutes to complete
the training, and were encouraged to discuss the informa-
tion between them. This level of training may be inad-
equate to provide sufficient understanding for physicians
to change their behaviour based on the CAT results, but is
often reflective of time and training available to primary
care physicians in real life. Practical educational ap-
proaches generally encourage more behavioural changes
[8], but this would not have been practical to implement
in this study. No specific guidelines were provided on ac-
tions to take based on the CAT score as such advice was
not available at the time.
Consultations
Physicians then undertook videoed consultations with
six standardised COPD patients. Each physician
conducted all their consultations either with or without
the CAT so that non-CAT consultations were not
influenced by questions / practices adopted in consulta-
tions with the CAT. After the consultation, physicians
were asked to record to camera their impression of the
case and recommended course of action – as if they
were making notes in the patient’s records.
Because of the practicalities of the study, the physi-
cians were meeting the patient actor for the first and
only time, which may have driven a different kind of
consultation compared with consecutive consultations.Table 1 Breakdown of physicians and assessors by
country
Physicians Group size Locations Assessors
Austria 24 6 2 N/A
France 39 5 4 5
Germany 38 5 4 9
Ireland 24 6 2 N/A
UK 40 5 4 10
Total 165 N/A 16 24
N/A: Not applicable.A physician first needs to build a relationship with the
patient, and then become acquainted with all his/her
diagnoses, of which COPD may be just one (and not al-
ways the most important). Additionally, a maximum
time was allowed for each consultation, with discussions
being interrupted and asked to finish after ten minutes,
limiting the time the physicians had to build that rela-
tionship. However, this is representative of real-life time
pressures in the primary care setting.
Interestingly, during validation work on the Clinical
COPD Questionnaire it was noted that physicians
changed their practices with experience of using the
PROM [9]. If this phenomenon is representative, the
utility of CAT may be different when the relationship
between the patient and physician is more established,
and in which the physician has a better understanding of
the patient’s history and situation.
Standardised patient cases
Pendleton’s tasks [10] are often used to assess the quality
of a consultation and have previously been used to as-
sess the communication of a healthcare provider with
their patient [11]. The tasks include “understanding the
patient issues”, and “involving the patient in the choice
of action”. Similar descriptions of what a good consult-
ation should achieve have been described by Howie [12]
and Mauksch [13], which include skills such as “topic
tracking”, “emphatic response to cues” [13], “patient
priorities” and “sharing decision making” [12]. The
expected impact of CAT is on the specific COPD con-
tent of the discussion, rather than physicians’ values and
personality. We therefore decided to assess the ability of
the physicians to identify ‘patient issues’, COPD specific
issues and management of these issues with and without
the CAT. These issues represented aspects of the pa-
tients’ medical history that needed to be addressed by
the physicians, such as depression, review of lifestyle or
therapy, and compliance issues.
The authors (including active clinicians from a variety
of different environments) constructed six cases to test
the utility of CAT across a range of scenarios, disease
burden and COPD patient issues (Table 2, Figure 2).
Some of the social aspects of each case were amended
slightly for each country, to ensure they resonated with
the physicians. The CAT scores of each case were inde-
pendently verified. Each case included four or five ‘pa-
tient issues’. While this allowed us to test the utility of
the CAT in the areas we believed it may impact, they
may not have represented valid patient scenarios, for ex-
ample the presence of several issues in each case. Alter-
native methods of creating the standardised cases, such
as selecting actual COPD patient cases, and have the ac-
tors portray those individual cases would have been
equally valid.
Table 2 Patient case summaries
Case Age FEV1 CAT Medical history Patient issues
1 68 40 34 Severe COPD, highly burdened by disease Mildly depressed; restricted in activities;
need for pulmonary rehabilitation
2 60 30 21 Sedentary lifestyle, post- severe exacerbation Loss of confidence; need for lifestyle &
therapy review
3 50 70 9 Recently diagnosed mild COPD, mild burden of disease Anxiety of diagnosis; need for lifestyle
advice & general COPD management
4 65 45 16 CV co-morbidity which being well treated,
but poorly managed COPD
Continued smoking & limited exercise;
impact of disease on activities; poor compliance
5 70 68 23 Severely limited by disease - overt depression Manifestations of depression; poor
compliance; need for pulmonary
rehabilitation & social support
6 63 65 19 Immigrated from Middle East / North Africa.
Suffering bad chest infection, wants antibiotics.
Highly burdened by cough
Doesn't believe he has COPD;
need to appreciate impact of
disease burden
Description of each of the six patient cases. Medical history briefly explains the case that was presented to the physician, while the patient issues are those
elements of the case that the physician needed to identify and address. FEV1: Forced Expiratory Volume in 1 second; COPD: Chronic Obstructive Pulmonary
Disease; CAT: COPD Assessment Test; CV: cardiovascular.
BA
Figure 2 Example COPD patient case. (A) Each case history was designed to cover a variety of disease severities and scenarios relevant to
clinical practice. (B) The actors provided completed CAT forms to physicians in the CAT+ arm. CAT scores for each case were independently
verified. FEV1: Forced Expiratory Volume in 1 second; BMI: Body Mass Index; COPD: Chronic Obstructive Pulmonary Disease; CAT: COPD
Assessment Test.
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CONFIDENTIAL Final version - 06/10/2010 
Protocol Identifier 
SCO114293 Link to video of case 4 Assessors Assessment Form 
Assessor Identifier 
Physician Identifier 
Consultation 
Score
0 = Not None 
1 = Some 
2 = High
Review of cough 
Review of mucus 
Review of chest tightening 
Review of breathlessness 
Review of daily activities 
Review of confidence  
Review of sleep 
Review of energy levels 
Review of exacerbations 
Review of smoking status 
Total (B / 20)
ASSESSMENT SCORE (A + B):
TIME TAKEN FOR CONSULTATION:
DIAGNOSIS GIVEN BY PHYSICIAN:
DIAGNOSIS SCORE (0 = poor, 1 = acceptable, 2 = accurate):
OVERALL ASSESSMENT GRADING (0 = very poor, 1 = poor, 2 = good, 3 = very good):
Case: 4 identified addressed Score 
Identifies continued smoking 
Manages CV risk 
Identifies restriction in activities 
Identify poor exercise regimen 
Identify poor treatment compliance 
Total Score (A / 20) 
XXXX
9999
4
2
2
0
1
2
2
1
1
1
2
4
3
1
2
4
2
2
1
2
2
0
0
0
0
2
14
9 min 0 sec
Mod COPD with CVD, increased alcohol / smoker with limited 
Accurate
Good
11
25
Figure 3 Example assessment sheet. Independent assessors
reviewed the videoed consultations, and scored the physician on
their ability to identify patient issues, review standard COPD
symptoms, understanding of the case and overall performance.
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performed the role of the COPD patients. Fluency was
confirmed by native speakers. Where language skills
allowed, actors were used in multiple countries (seven
actors only performed in one country, eleven actors
performed in two countries, and two actresses
performed in 3 countries), increasing the consistency
with which the cases were presented to the physicians.
Many of the actors were either native to, or had spent
significant time living in the countries where the study
was conducted. In addition, they spent time with local
COPD patients to ensure they portrayed a COPD patient
as socially and linguistically accurately as possible. The
actors were trained in clinical aspects of COPD, details
of their case and not to proactively raise their ‘patient is-
sues’ with the physician, who needed to uncover them
by direct enquiry.
Using actors to portray standardised cases provides
confidence that differences seen in a study are due to
the intervention, rather than differences in case presen-
tations, especially as the study needed to run over sev-
eral countries and several months. The use of trained
actors to play standardised patients has been successfully
used before in other studies assessing the behaviours of
physicians [14,15], and by the Royal College of General
Physicians in the assessment of primary care physicians
in the UK. There is often a concern that simulated sur-
geries compromise the realism of the case, and the be-
haviour of the physician may be altered by knowledge of
being observed (Hawthorne effect). However, physicians
frequently report face-validity of patient actors [15], and
the use of simulated consultations for the testing of an
instrument’s properties is widely accepted and consid-
ered useful [16]. Additionally any impact of loss of
realism could reasonably be expected to be similar for
physicians in both arms.
Assessment criteria
Independent assessors (n=24) with experience of assessing
physician performance (e.g. through primary care qualifi-
cation assessments, physician education programs), had
experience of COPD management, but who were not part
of the development of the CAT, assessed the videoed con-
sultations. German and UK assessors also assessed Aus-
trian and Irish physicians respectively (Table 1).
All independent assessors were trained by HM
through individual or small group telephone discussions.
Assessors scored each physician on whether they identi-
fied and addressed the relevant ‘patient issues’ and
reviewed ten standard COPD aspects such as cough and
smoking history (0 = none, 1 = some, 2 = high). Scores
were captured on an online score sheet, and the patient
issues scores (sub-score A, out of 20) and COPD review
scores (sub-score B, out of 20) were calculated. A globalscore of sub-score A plus sub-score B was calculated as
a composite endpoint (Figure 3). A ‘some’ score for sub-
score A and sub-score B was given when the physician
had gained a superficial appreciation of the patient issue;
while a ‘high’ score was awarded when the physician
asked a number of insightful questions to fully under-
stand the issue, the burden on the patient and how the
situation might be improved. The independent assessors
also rated the physician’s understanding of the case from
their description to camera (“understanding score”: poor,
acceptable, accurate) and their overall performance (very
poor, poor, good, very good). Similar to the sub-score
grading scheme, an ‘acceptable’ understanding score was
given when the physician had understood the key ele-
ments of the case, while an ‘accurate’ score was awarded
when the physician demonstrated a deep and full under-
standing of the case. Overall performance summarised
the whole consultation including, for example how the
physician behaved in the consultation, empathy etc.
Although the assessors from UK and Germany were
trained to judge Irish and Austrian physicians in the same
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assessment differed due to cultural or health care system
differences though it is unlikely that any impact from
these differences would be different in the two arms.
These assessment criteria were prospectively created
specifically for this study to test the utility of the CAT in
the areas that we believed it might impact. They were
not tested for assessor interpretation, inter- and intra-
assessor consistency of marking or sensitivity (relative
importance of each item on the quality of the consult-
ation). The global score of sub-score A plus B was
chosen as the primary endpoint as this is the most con-
servative endpoint, so we were not setting up the study
for guaranteed success.
Alternative methods of assessing physician behaviour
have been described previously [16-18]. The Consult-
ation Quality Index-2 (CQI-2) measures the holistic
quality of the consultation, including patient enable-
ment, empathy and patient satisfaction [18], and so may
not have been sufficiently sensitive to measure the im-
pact upon a consultation that we expected the CAT to
achieve. Similarly, the Roter’s Interaction Analysis Sys-
tem (RIAS) [17] focuses on the physicians psychosocial
behaviour and quality of management of the patient:
physician relationship, and as such may miss the
expected impact of the CAT. The Medication-Related
Consultation Framework (MRCF) tool assesses medica-
tion related consultations and focuses on the discussion
content between a patient and pharmacist [16]. This tool
includes sections on “data collection and problem identi-
fication” and “actions and solutions”, with the questions
primarily assessing the patient:pharmacist discussion
around medication use. The questionnaire is quite long
(46 items), aimed at pharmacists, and - as medication
compliance is only a small part of primary care consulta-
tions – would miss other discussion that the CAT may
influence. We therefore felt that none of these
established consultation assessment tools would have
provided a sound basis of assessment of the impact of
the CAT in the primary care setting.
Actor feedback is frequently used in studies of phys-
ician behaviour and is often found to be predictive of
real patient feedback [15], with acceptably small variance
between different actors [19]. Therefore the actors pro-
vided feedback following each consultation on whether
they felt the physician addressed their issues by scoring
5 questions (such as “I felt the physician understood my
issues”, “The physician helped me address my issues”) as
“no”, “yes, but unsatisfactory” or “yes”. These questions
were based on a similar questionnaire used to gather
feedback on the healthcare service provided to UK
COPD patients. The actors also provided feedback
on the length of the consultation, and their overall
satisfaction.Feasibility
We conducted a pilot study to confirm the feasibility and
inform the sample size of the study. The methodology as
described above was used with ten UK Physicians. Only
minor technical issues were identified with the recruit-
ment of physicians, consultation filming, and assessments,
which were resolved in time for the main study.
The assessment of the physicians in the pilot study
was conducted by some of the authors (SH, JR, GN and
DL). The mean global score across the cases ranged be-
tween 12.8 and 19.0 in the no CAT arm, and 16.0 and
25.3 in the CAT+ arm (Table 3); and the difference be-
tween the arms, ranged between 3.2 and 12.3. The per-
cent of “good” or “very good” consultations rose by up
to 40 percentage points in the CAT+ arm.
The results from the pilot study indicate the assessment
items and scoring system employed were sufficient to
identify differences between good and poor consultations.
Assessor scoring variability
A large number of independent assessors, from 3 diffe-
rent countries, were required to assess the volume of
consultations which introduced significant complexity to
the analysis of the study. Additionally, it was not pos-
sible to blind the assessors to the presence of the CAT
from the consultation, which may have biased their scor-
ing. Alternative methodologies, such as audio taped con-
sultations, would not necessarily have resolved this. We
conducted a benchmarking exercise to gauge whether
these aspects would impact upon the final result of the
study. The intention was to assess the variability in the
assessors’ scores and to identify any outlying assessor(s).
Each assessor therefore reviewed two high-scoring and
two low-scoring consultations from the pilot study, with
and without CAT.
The actual scores given by each assessor varied signifi-
cantly, and a difference in mean total scores across the
countries were identified; however the ranking and dif-
ferences between the high and low scoring assessments
were generally consistent (Figure 4). The inter-assessor
reliability was analysed. The intraclass correlation coeffi-
cient (ICC) was 0.68 [95% CI 0.38; 0.97], p<0.001, and
no atypical assessor was identified.
The benchmarking analysis also suggested that ‘case’
was as much a factor in the different scores as the asses-
sor – i.e. variability in the actual score across the asses-
sors was not obscuring the difference between the cases.
To account for these effects, assessor and case were in-
cluded as adjustment variables in the statistical analyses.
Statistical aspects
The primary endpoint for the study was mean global
score (combined sub-scores A and B, which had a scale
of 0 (worst) to 40 (best)). For the one case which only
Table 3 Pilot study results
Case NO-CAT CAT+
mean score (SD) mean score (SD)
Case 1 13.3 +/− 4.0 22.0 +/− 10.1
Case 2 13.0 +/− 5.6 25.3 +/− 6.4
Case 3 12.8 +/− 2.2 16.0 +/− 5.0
Case 4 16.0 +/− 9.7 19.3 +/− 11.9
Case 5 13.8 +/− 9.4 18.5 +/− 9.3
Case 6 19.0 +/− 9.5 24.6 +/− 8.2
Mean Global score from pilot study, by case. SD: Standard deviation.
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with five, sub-score A results were scaled up (multiplied
by 1.25) to make it comparable. Since the primary end-
point had not been previously trialled, the sensitivity or
potential magnitude of difference between the arms was
unknown. The investigators agreed that a difference of
10% (i.e. 4 points) between the arms would be convin-
cing as a true difference. The pilot study data indicated
that this difference was realistic, and that a conservative
estimation of standard deviation was 12 points. There-
fore, in order to achieve 90% power to detect a differ-
ence of at least 3 points in global score in the main
study 752 consultations were needed, allowing for 10%
missing data. No adjustments for confounders were
included. Given the number of patient consultations34
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Figure 4 Benchmarking assessment scores. Each assessor reviewed 4 se
of scoring between assessors, and to identify any outliers. Assessors review
consultation without CAT (Case 2); a high scoring consultation without CAcreated at each session and location, the number of
planned patient consultations was 960.
Sub-scores A and B, were also designated as secondary
outcomes; all scores were analysed using repeated-
measures analysis of variance with a linear mixed model.
Differences in items of global score, and of sub-scores A
and B were tested with a chi-square test or a Fisher’s exact
test. ‘Understanding score’ and ‘overall assessment’ grading
were analysed with a generalized estimating equations
model. To account for the assessor effect, as identified in
the benchmarking exercise, both assessor and case were
included as adjustment variables in the models. The order
in which physicians saw the cases was also included to ac-
count for any training effect. A secondary analysis where
physician characteristics, including country, were explored
as potential confounders was conducted to confirm the
generalisability of the study results across multiple coun-
tries. Similarly a sensitivity analysis including all physi-
cians who participated in the study was conducted. The
statistical analysis was conducted using SAS v9.1.
Concluding remarks
This novel study was designed to assess the impact of
the CAT on the behaviour of a physician in their con-
sultation with a COPD patient. At the time the study
was run there was no guidance available on managing
COPD patients based on their CAT scores. As such we1 46
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t cases, and the Global scores were compared to assess the variability
ed a low scoring consultation with CAT (Case 1); a low scoring
T (Case 4); a high scoring consultation with CAT (case 6)
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therapy and management choices made by the physician
and patient. This situation has subsequently changed as
CAT is now forms part of the Global Initiative for
Chronic Obstructive Lung Disease (GOLD) 2011 COPD
assessment framework, alongside spirometry and exacer-
bation history [20]. Additionally, this methodology
would not be able to evaluate the impact of CAT on
long-term management and outcomes. Further studies
on the CAT specifically are warranted.
To ensure a fair comparison between the arms in this
study, we needed to take steps to ensure that potential
confounders such as underlying knowledge of the physi-
cians, suitability of the assessment criteria, and variabil-
ity of the assessors were as controlled as possible.
Although there are still some limitations, the study de-
sign allows standardisation of the cases and analysis, and
could be used to assess the utility of other PROMs by
direct observation of clinical practice.
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